SWK
SWKH | NASDAQ
$15.90
$0.00 (0.00%)
At close: Apr 2, 2026, 4:00 PM ET
SWK Company Profile
Company profile explainedCompany Profile
SWK Holdings Corporation (SWKH) operates as a specialized financial institution, primarily concentrating its efforts within the healthcare sector. The company's operations are distinctly divided into two core segments: Finance Receivables and Pharmaceutical Development. Within its finance division, SWK offers bespoke funding solutions tailored to a diverse array of life science enterprises. These include companies spanning biotechnology, medical devices, diagnostic tools, animal health, and pharmaceuticals, alongside various institutions and individual innovators. Furthermore, the company extends non-discretionary investment advisory services, managing separate accounts for institutional clients keen on investing in the life science finance domain. Its Pharmaceutical Development segment involves the creation, formulation, production, and licensing of pharmaceutical products, leveraging its proprietary Peptelligence platform. A key strategic objective here is to license its internally developed product pipeline to external partners, aiming to generate innovative formulations through its unique technology, ultimately designed to benefit patients and their caregivers. Founded in 1996, the company underwent a name change from Kana Software, Inc. to SWK Holdings Corporation in December 2009. Its corporate headquarters are situated in Dallas, Texas.
Key Executives
| Name | Position |
|---|---|
| Jody Staggs | Chief Executive Officer & President |
| Adam Christopher Rice | Chief Financial Officer |
| Courtney Baker | Controller |
| David R. Earhart | General Counsel & Secretary |
| John David Tamas | Director of Underwriting |
| Kendall Bardin | Director of HR |
| Michael Miner | Vice President |
| Peter Blumberg | Vice President of Originations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 23, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Apr 16, 2026 | 15-12G | Filing |
| Apr 08, 2026 | EFFECT | Filing |
| Apr 08, 2026 | EFFECT | Filing |
| Apr 08, 2026 | SC 13D/A | [Amend] Filing |
| Apr 08, 2026 | 4 | Filing |
| Apr 07, 2026 | S-8 POS | Filing |
| Apr 07, 2026 | S-8 POS | Filing |
| Apr 07, 2026 | S-8 POS | Filing |
| Apr 07, 2026 | S-8 POS | Filing |
SWK
| Country | United States |
| IPO Date | Sep 23, 1999 |
| Industry | Asset Management |
| Sector | Financial Services |
| Employees | 24 |
| CEO | Jody. D Staggs |
Contact Details
14755 Preston Road Dallas,
Texas 75254 United States
Stock Details
| Ticker Symbol | SWKH |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001089907 |
| CUSIP Number | 78501P203 |
| ISIN Number | US78501P2039 |
| SIC Code | 6159 |
Add to Watchlist
Select watchlists to add or remove SWKH